期刊文献+

Blue mode does not offer any benefit over white light when calculating Lewis score in small-bowel capsule endoscopy 被引量:3

下载PDF
导出
摘要 AIM: To check the usefulness of blue mode (BM) review in lewis score (LS) calculation, by comparing it with respective LS results obtained by white light (WL) small-bowel capsule endoscopy (SBCE) review and mucosal inflammation as reflected by faecal calprotectin (FC) levels, considered as ‘gold standard’ for this study. METHODS: Computational analysis of our SBCE database to identify patients who underwent SBCE with PillCam? and had FC measured within a 30-day period from their test. Only patients with prior colonoscopy were included, to exclude any colon pathology-associated FC rise. Each small bowel tertile was reviewed (viewing speed 8 fps) with WL and BM, in a back-to-back mode, by a single experienced reviewer. LS were calculated after each WL and BM reviews. Pearson rank correlation (rho, r) statistic was applied. RESULTS: Twenty-seven (n = 27, 20F/7M) patients were included. Thirteen (n = 13) had SBCE with PillCam?SB1, and the remainder (n = 14) with PillCam?SB2. The median level of FC in this cohort was 125 μg/g. LS (calculated in WL SBCE review) correlation with FC levels was r = 0.490 (P = 0.01), while for BM review and LS correlation with FC was r = 0.472 (P = 0.013). CONCLUSION: Although BM is believed to enhance mucosal details i.e., small mucosal breaks, it did not perform better than WL in the calculation of LS in our cohort. AIM: To check the usefulness of blue mode (BM) review in lewis score (LS) calculation, by comparing it with respective LS results obtained by white light (WL) small-bowel capsule endoscopy (SBCE) review and mucosal inflammation as reflected by faecal calprotectin (FC) levels, considered as ’gold standard’ for this study. METHODS: Computational analysis of our SBCE database to identify patients who underwent SBCE with PillCam? and had FC measured within a 30-day period from their test. Only patients with prior colonoscopy were included, to exclude any colon pathology-associated FC rise. Each small bowel tertile was reviewed (viewing speed 8 fps) with WL and BM, in a back-to-back mode, by a single experienced reviewer. LS were calculated after each WL and BM reviews. Pearson rank correlation (rho, r) statistic was applied.RESULTS: Twenty-seven (n = 27, 20F/7M) patients were included. Thirteen (n = 13) had SBCE with PillCam?SB1, and the remainder (n = 14) with PillCam? SB2. The median level of FC in this cohort was 125 μg/g. LS (calculated in WL SBCE review) correlation with FC levels was r = 0.490 (P = 0.01), while for BM review and LS correlation with FC was r = 0.472 (P = 0.013).
出处 《World Journal of Gastrointestinal Endoscopy》 CAS 2012年第2期33-37,共5页 世界胃肠内镜杂志(英文版)(电子版)
  • 相关文献

参考文献21

  • 1Dr. A. Leis.Telemedizin heute[J]. Der Unfallchirurg . 2008 (3)
  • 2Doherty GA,Moss AC,Cheifetz AS.Capsule endoscopy for small-bowel evaluation in Crohn’’s disease. Gastrointestinal Endoscopy . 2011
  • 3Bourreille A,Ignjatovic A,Aabakken L,Loftus EV,Eliakim R,Pennazio M,Bouhnik Y,Seidman E,Keuchel M,Albert JG,Ardizzone S,Bar-Meir S,Bisschops R,Despott EJ,Fortun PF,Heuschkel R,Kammermeier J,Leighton JA,Mantzaris GJ,Moussata D,Lo S,Paulsen V,Panés J,Radfo.Role of small-bowel endoscopy in the management of patients with in? ammatory bowel disease: an international OMED-ECCO consensus. Endoscopy . 2009
  • 4Sidhu R,Brunt LK,Morley SR,Sanders DS,McAlindon ME.Undisclosed use of nonsteroidal anti-inflammatory drugs may underlie small-bowel injury observed by capsule endoscopy. Clinics in Gastroenterology . 2010
  • 5Krystallis C,Koulaouzidis A,Douglas S,Plevris JN.Chromoendoscopy in small bowel capsule endoscopy: Blue mode or Fuji Intelligent Colour Enhancement?. Digestive and Liver Disease . 2011
  • 6Manolakis AC,Kapsoritakis AN,Tiaka EK,Potamianos SP.Calprotectin, calgranulin C, and other members of the s100 protein family in in? ammatory bowel disease. Digestive Diseases and Sciences . 2011
  • 7Logan R.Faecal calprotectin for the diagnosis of inflammatory bowel disease. British Medical Journal . 2010
  • 8van Rheenen PF,Van de Vijver E,Fidler V.Faecal calprotectin for screening of patients with suspected in? ammatory bowel disease: diagnostic meta-analysis. British Medical Journal . 2010
  • 9Zippi M,Al Ansari N,Siliquini F,Severi C,Kagarmanova A,Maffi a C,Parlanti S,Garbarino V,Maccioni F.Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of in? ammatory pattern in Crohn’’s disease. Clinica Terapeutica . 2010
  • 10Koulaouzidis A,,Douglas S,Rogers MA,Arnott ID,Plevris JN.Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bidirectional endoscopy. Scandinavian Journal of Gastroenterology . 2011

共引文献2

同被引文献99

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部